Printer Friendly
The Free Library
14,550,595 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AlphaRx to Present Research Paper at the 28th International Symposium on Controlled Release of Bioactive Materials Conference.


Business Editors, Health/Medical Writers

BIOWIRE2K

RICHMOND HILL, Ontario--(BW HealthWire)--May 31, 2001

AlphaRx Inc. (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:AHRX) announced today it will present the results of its human clinical trial on Coenzyme coenzyme (kō-ĕn`zīm), any one of a group of relatively small organic molecules required for the catalytic function of certain enzymes.  Q-10 in a research paper entitled "Increased Bioavailability bioavailability /bio·avail·a·bil·i·ty/ (bi?o-ah-val?ah-bil´i-te) the degree to which a drug or other substance becomes available to the target tissue after administration.

bi·o·a·vail·a·bil·i·ty
n.
 of Coenzyme Q-10 In Self-Emulsifying Controlled Release Tablet: New Type of Delivery System for Hydrophobic Drugs" at the 28th Controlled Release Society Symposium.

The paper will document the superiority of AlphaRx's Self-Emulsifying Controlled Release Tablet (S.E.C.R.E.T.) technology in the oral delivery of Coenzyme Q-10 and other hydrophobic drugs.

Formulating deliverable hydrophobic drug molecules remains a difficult task in pharmaceutical development. Traditional lipid-based drug delivery systems utilizing soft or hard gelatin gelatin or animal jelly, foodstuff obtained from connective tissue (found in hoofs, bones, tendons, ligaments, and cartilage) of vertebrate animals by the action of boiling water or dilute acid.  oral capsules require dedicated, expensive equipment for their manufacture and offer limited control over the timing of drug release. By comparison, AlphaRx's unique S.E.C.R.E.T. polymeric tablet drug delivery system can be fabricated with existing generic pharmaceutical manufacturing technology and supports a flexible drug release profile, including once-a-day dosing.

The 28th International Symposium on Controlled Release of Bioactive Materials Conference convenes in San Diego, California “San Diego” redirects here. For other uses, see San Diego (disambiguation).
San Diego is a coastal Southern California city located in the southwestern corner of the continental United States. As of 2006, the city has a population of 1,256,951.
 from June 24, 2001 to June 27, 2001. This conference is sponsored by the Controlled Release Society (CRS CRS Course
CRS Certified Residential Specialist (real estate certification)
CRS Central Reservation System
CRS Can't Remember Stuff (polite form)
CRS Cost Reduction Strategy
CRS Consumer Relations Specialist
), an international organization of 2,600 academic and industrial research experts in drug delivery technology from over fifty countries, who meet annually to assess advances in their field.

"We are pleased to have been invited to present our Company's technology at the annual CRS Symposium. This is a most prestigious scientific forum, which showcases state-of-the-art advances in drug delivery research & development, " said Mr. Michael Lee, President of AlphaRx.

About AlphaRx

AlphaRx Inc. is a leading drug delivery company that develops and markets innovative therapeutic products based on its proprietary Bioadhesive Colloidal colloidal

of the nature of a colloid.


colloidal bath
a bath containing gelatin, bran, starch or similar substances, to relieve skin irritation and pruritus.
 Dispersion drug delivery systems. For additional information about us, please visit our website at www.AlphaRx.com

FORWARD LOOKING STATEMENTS:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute.

When a person begins a civil lawsuit, the person enters into a process called litigation.
 Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:May 31, 2001
Words:375
Previous Article:Mobility Technologies Offers Exclusive Data, Technology With 'Traffic Pulse Partner Program'.
Next Article:Entegris Completes Acquisition of NT International; Measurement Technology Widens Company's Broad Line of Fluid Handling Products.



Related Articles
Whole grains have several positive impacts on health.
NIST CO-SPONSORED EIGHTH INTERNATIONAL SYMPOSIUM ON BIOLOGICAL AND ENVIRONMENTAL REFERENCE MATERIALS (BERM-8).
NDIA: Event.
Calendar.(Calendar)
ISCC Annual Meeting and CORM Technical Meeting to be held in conjunction at NIST site on May 10-11, 2004.
TAPPI Conference Proceedings and Short Course Notes.(GENERAL INTEREST)
Smart Coatings 2006 call for papers.(Industry Events)
Coatings Research Institute to hold Smart Coatings conference February 15-17, in Orlando, FL.(Meetings Update)
Jonathan W. Martin to receive 2006 Roy W. Tess Award.(Business & Industry)
4th International Symposium on Service Life Prediction slated for December 3-8, 2006, in Key Largo.(Meetings Update)(Calendar)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles